Search

Home > New FDA Approvals > 031 – FDA expands approval of Pfizer’s Sutent (sunitinib) to reduce the risk of kidney cancer returning; FDA approves Genentech’s Hemlibra (emicizumab-kxwh) to prevent bleeding in certain patients with hemophilia A; FDA announces comprehensive regen


	Podcast:		New FDA Approvals
	Episode:		031 – FDA expands approval of Pfizer’s Sutent (sunitinib) to reduce the risk of kidney cancer returning; FDA approves Genentech’s Hemlibra (emicizumab-kxwh) to prevent bleeding in certain patients with hemophilia A; FDA announces comprehensive regen
	Category:		Science & Medicine
	Duration:		00:10:31
	Publish Date:		2017-11-17 07:00:00
	Description:		November 17, 2017 0:27 - FDA expands approval of Pfizer’s Sutent (sunitinib) to reduce the risk of kidney cancer returning https://www.fda.gov/newsevents/newsroom/pressannouncements/default.htm 2:43 - FDA approves Genentech’s Hemlibra (emicizumab-kxwh) to prevent bleeding in certain patients with hemophilia A https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm585567.htm 6:15 FDA announces comprehensive regenerative medicine policy framework https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm585657.htm https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm585342.htm If we can help with any medical writing, please reach out to us at info@nascentmc.com Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. We charge a flat rate and provide an upfront estimate. Our turn around times can be as short as 1 to 2 days depending on the length of the project, and we don't charge extra for our speediness. Have you updated your blog or posted any press releases lately? That's a small project that some clients like to test us out with to start. We do the following types of writing, including but not limited to: -Video and virtual reality script writing -eLearning scripts -Medical education -Webinar slide creation -Manuscripts -Slidesets -Manuscripts -Press releases -Blog posts -Annual reports -Proposals -White papers -Web content -Posters -Sales training materials
	Total Play:		0